Targeting IL-4 for the Treatment of Atopic Dermatitis

被引:0
|
作者
Chiricozzi, Andrea [1 ,2 ]
Maurelli, Martina [3 ]
Peris, Ketty [1 ,2 ]
Girolomoni, Giampiero [3 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dermatol, Rome, Italy
[3] Univ Verona, Dept Med, Sect Dermatol, Verona, Italy
关键词
atopic dermatitis; IL-4; inhibitor; dupilumab; pascolizumab; pitrakinra; TH2; CYTOKINES; STAPHYLOCOCCUS-AUREUS; DERMAL FIBROBLASTS; DENDRITIC CELLS; TRANSGENIC MICE; LESIONAL SKIN; UP-REGULATION; IFN-GAMMA; IN-VITRO; T-CELLS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Atopic dermatitis (AD) is an immune-mediated inflammatory skin disease characterized by a predominant type 2 immune response. Type 2 immunity is driven by multiple cytokines, including interleukin (IL)-4 and IL-13 that are considered central to AD pathogenesis and key therapeutic targets. The dual inhibition of these two cytokines or the selective inhibition of IL-13 proved elevated efficacy in treating AD, whereas the selective inhibition of IL-4 has been poorly investigated as IL-4 inhibiting agents did not show any advance in clinical development programs. This review describes the pathogenic role of IL-4 in AD and briefly resumes the main features of compounds selectively blocking IL-4.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 50 条
  • [31] Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element
    Chan, SC
    Brown, MA
    Willcox, TM
    Li, SH
    Stevens, SR
    Tara, D
    Hanifin, JM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (05) : 1131 - 1136
  • [32] Adhesion molecule expression on skin endothelia in atopic dermatitis:: Effects of TNF-α and IL-4
    de Vries, IJM
    Langeveld-Wildschut, EG
    van Reijsen, FC
    Dubois, GR
    van den Hoek, JA
    Bihari, IC
    van Wichen, D
    de Weger, RA
    Knol, EF
    Thepen, T
    Bruijnzeel-Koomen, CAFM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (03) : 461 - 468
  • [33] Therapeutic strategies in extrinsic atopic dermatitis: focus on inhibition of IL-4 as a new pharmacological approach
    Di Lernia, Vito
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (01) : 87 - 96
  • [34] Phosphodiester-CpG-ODN-mediated prevention of atopic dermatitis through IL-4 inhibition
    Na, K.
    Jeon, M.
    Kim, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S114 - S114
  • [35] Alterations induced by IL-4, IL-13 and IL-25 in a reconstructed human epidermis are reminiscent of atopic dermatitis
    De Vuyst, E.
    Giltaire, S.
    de Rouvroit, C. Lambert
    Chretien, A.
    Salmon, M.
    Poumay, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S4 - S4
  • [36] Topical Application of a PDE4 Inhibitor Ameliorates Atopic Dermatitis through Inhibition of IL-4 Production
    Takahashi, Kazufusa
    Miyake, Kensuke
    Ito, Junya
    Shimamura, Hinano
    Suenaga, Tadahiro
    Karasuyama, Hajime
    Ohashi, Kenichi
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (05) : 1048 - 1057.e8
  • [37] Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
    Lytvyn, Yuliya
    Gooderham, Melinda
    PHARMACEUTICS, 2023, 15 (02)
  • [38] Association of IL-4, IL-10 and TGF-beta cytokine gene polymorphisms in children with atopic dermatitis
    Stavric, K.
    ALLERGY, 2012, 67 : 139 - 139
  • [39] IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis
    Grolleau, Chloe
    Calugareanu, Andreea
    Demouche, Sarah
    Nosbaum, Audrey
    Staumont-Salle, Delphine
    Aubert, Helene
    Cassius, Charles
    Jachiet, Marie
    Saussine, Anne
    Bagot, Martine
    Bachelez, Herve
    Battistella, Maxime
    Hotz, Claire
    Du Thanh, Aurelie
    Crepy, Marie-Noelle
    Bergerat, David
    Merandet, Marine
    Onifarasoaniaina, Rachel
    Alberdi, Antonio
    How-Kit, Alexandre
    Bouaziz, Jean-David
    Le-Buanec, Helene
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : 711 - +
  • [40] A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis
    Bitton, Almog
    Avlas, Shmuel
    Reichman, Hadar
    Itan, Michal
    Karo-Atar, Danielle
    Azouz, Nurit P.
    Rozenberg, Perri
    Diesendruck, Yael
    Nahary, Limor
    Rothenberg, Marc E.
    Benhar, Itai
    Munitz, Ariel
    SCIENCE IMMUNOLOGY, 2020, 5 (44)